Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab
Clinical trial NCT04748419 · TERMINATED
Trial details
- NCT number
- NCT04748419
- Sponsor
- University of Nebraska
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2025-09-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.